Humasis Co

Humasis Co ROA

The Return on Assets (ROA) of Humasis Co (205470.KQ) as of Nov 11, 2026 is -4.78 %. In the previous year, Return on Assets (ROA) was -9.17 % — a change of -47.92% (higher).

ROA

-4.78 %

YoY

-47.92%

Last updated:

In 2025, Humasis Co's return on assets (ROA) was -4.78 %, a -47.92% increase from the -9.17 % ROA in the previous year.

The Humasis Co ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
-2.49 KRW
Jan 1, 2019
-3.36 KRW
Jan 1, 2020
30.85 KRW
Jan 1, 2021
44.38 KRW
Jan 1, 2022
39.06 KRW
Jan 1, 2023
-15.96 KRW
Jan 1, 2024
-9.17 KRW
Jan 1, 2025
-4.78 KRW
The Humasis Co ROA history
YEARROAYoY
-4.78 %-47.92%
-9.17 %-42.53%
-15.96 %-140.85%
39.06 %-11.98%
44.38 %+43.87%
30.85 %-1,017.88%
-3.36 %+35.14%
-2.49 %-85.07%
-16.65 %-1,926.17%
0.91 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Humasis Co Stock analysis

What does Humasis Co do? Humasis Co., Ltd. develops rapid test kits and point-of-care testing instruments for the domestic and overseas markets. The company manufactures immunoquantitative analysis devices, myocardial infarction test equipment, infectious disease detection devices, hormone test devices, and cancer marker test devices. It also researches and develops biomaterials. Humasis sells its products to customers in South Korea and international markets, focusing on healthcare providers and medical institutions that require diagnostic tools for diseases like heart attacks, infections, and cancer. The company's revenue comes from the sale of its diagnostic devices and biomaterials research. Products include immunoquantitative analysis devices, myocardial infarction test equipment, and cancer marker test devices. These are sold to healthcare providers and medical institutions in South Korea and overseas. Humasis targets segments in the medical diagnostics field, particularly for cardiovascular, infectious disease, and oncology applications. Humasis Co., Ltd. operates in the medical device sector, focusing on point-of-care testing solutions. Its product portfolio includes devices for myocardial infarction, infectious diseases, hormones, and cancer markers. The company's sales are driven by demand from hospitals and clinics that need rapid diagnostic tools for patient care. The firm's research and development in biomaterials supports its product offerings in the medical diagnostics market. Humasis Co is one of the most popular companies on Eulerpool.

ROA Details

Understanding Humasis Co's Return on Assets (ROA)

Humasis Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Humasis Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Humasis Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Humasis Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Humasis Co stock

Return on Assets (ROA) of Humasis Co is -4.78 % in 2025.

Return on Assets (ROA) of Humasis Co changed from -9.17 % to -4.78 %, representing a -47.92% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Humasis Co since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Humasis Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Humasis Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Humasis Co